Plasma Epstein–Barr Viral Deoxyribonucleic Acid Predicts Worse Outcomes in Pediatric Nonmetastatic Nasopharyngeal Carcinoma Patients: An Observational Study of 89 Cases in an Endemic Area

To evaluate the clinical significance of pretreatment levels of plasma Epstein–Barr virus DNA (pEBV DNA) on prognoses in pediatric nasopharyngeal carcinoma (NPC) patients. Eighty-nine patients aged 21 years old or younger with nonmetastatic NPC were evaluated to determine the effect of pEBV DNA leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Ting, Tang, Lin-Quan, Gu, Wei-Guang, Luo, Dong-Hua, Chen, Qiu-Yan, Li, Pei-Jing, Mai, Dong-Mei, Mai, Hai-Qiang, Mo, Hao-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058881/
https://www.ncbi.nlm.nih.gov/pubmed/26683909
http://dx.doi.org/10.1097/MD.0000000000001945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058881/
https://www.ncbi.nlm.nih.gov/pubmed/26683909
http://dx.doi.org/10.1097/MD.0000000000001945

Ejemplares similares